Food industry
Pharmaceutical industry & health
Art and restoration
Fine-chemistry (Thin film coatings)
Semi-conductor industry

Forensic sciences
Carbon nanomaterials

youtube twitter linkedin staafje
  • microscoop-2
  • Raman spectrum-3a
  • msf9 eds a

Cancer-ID: major Dutch program to start

The Cancer-ID program, in which HybriScan Technologies partcipates, starts on April 10th. The aim of the Cancer-ID program is to develop novel technology for monitoring Cancer therapy through revealing the extracellular vesicle IDentity (Cancer-ID). HybriScan Technologies will supply a HybriScan Raman Microscope that is integrated with a JEOL scanning electron microscope (SEM).

Hybrican will assist University of Twente in related research as well. "By the ability of combining imaging of data with chemical analysis HybriScan contributes with a distinctive tool in important research to learn more about these vesicles originating from cancer cells", stresses Loretta van Kollenburg, CEO of Arnhem based Hybriscan.

In the STW perspective program ‘New technology for monitoring cancer therapy through extracellular vesicle identity’, innovative technologies will be developed for the detection and characterization of vesicles that are secreted by cells. Because they are very small (50-1000 nm), present techniques are inadequate for clinical vesicle detection, however vesicles do contain clinical information about, for example, cancer, allergies, vascular disorders, and autoimmune diseases.

Read more about Cancer-ID program

Since May this year Hybriscan is already working together with the AMC in Amsterdam on detection and characterisation of microvesicles. This AMC/HybriScan project is developing an integrated optics and microfluidics platform that can determine the concentration and origin of infrequent vesicles or bacteria in liquid. The role of Hybriscan is correlating size with chemical composition of microvesicles.